Krka is among top generic pharmaceutical companies in the world. We have now been successfully implementing our strategies and pursuing our mission and vision for over half a century.
Line of business
Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company’s activities are supplemented by health resort and tourist services.
Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.
Research and development
At Krka we develop innovative generic medicines, i.e. generic medicines with value added, which are the product of our own in-house knowledge, and provide our products with major advantages for years after market entry. All our pharmaceuticals offer high quality, efficacy and safety. Our products are marketed under our own brands.
As a generic producer, Krka is responsible for medicines that can take their place alongside the world’s leading pharmaceutical companies in terms of quality, safety and efficacy. Quality, in the broadest sense of the word, is created, maintained, and the responsibility of all employees. Krka’s systematic approach is intended to ensure it exceeds customer requirements and achieve its set operating objectives.
Krka's strategy for own-brand generic pharmaceutical development is achieved through investment in research and development capacity and Krka's own production and distribution centres around the world.
Krka’s business performance is based on the commitment and the knowledge of its employees. At Krka we are committed to acquiring, motivating and retaining dedicated and capable staff and building an international corporate culture. Investment in knowledge and the development of all our employees helps them to become among the very best in their own fields of work.